• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    EVP & CFO Cleminson Ian sold $431,679 worth of shares (4,275 units at $100.98), decreasing direct ownership by 21% to 15,858 units (SEC Form 4)

    3/4/25 6:44:58 PM ET
    $IOSP
    Major Chemicals
    Industrials
    Get the next $IOSP alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Cleminson Ian

    (Last) (First) (Middle)
    8310 SOUTH VALLEY HIGHWAY
    SUITE 350

    (Street)
    ENGLEWOOD CO 80112

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    INNOSPEC INC. [ IOSP ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    EVP & CFO
    3. Date of Earliest Transaction (Month/Day/Year)
    03/03/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 03/03/2025 S 4,275 D $100.9775 15,858 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Ian Philip Cleminson 03/04/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $IOSP alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IOSP

    DatePrice TargetRatingAnalyst
    4/21/2025$115.00Neutral → Buy
    Seaport Research Partners
    3/30/2022Neutral
    Seaport Research Partners
    More analyst ratings

    $IOSP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parrette Leslie J sold $40,421 worth of shares (446 units at $90.63), decreasing direct ownership by 8% to 5,497 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/15/25 9:11:51 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SVP, HUMAN RESOURCES Griffin Hardy Louis Iii covered exercise/tax liability with 600 shares, decreasing direct ownership by 8% to 6,742 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/15/25 9:05:37 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SVP, Corporate Dev and IR Barnes Corbin covered exercise/tax liability with 740 shares, decreasing direct ownership by 8% to 8,998 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/15/25 9:01:11 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Innospec Reports Second Quarter 2025 Financial Results

    Strong growth in Fuel Specialties operating income offsetting lower results in our other businesses Focus on sequential gross margin and operating income improvement in the second half of the year Debt-free balance sheet with over $266 million in net cash; $8.2 million in share repurchases GAAP EPS 94 cents and adjusted non-GAAP EPS $1.26 ENGLEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the second quarter ended June 30, 2025. Total revenues for the second quarter were $439.7 million, an increase of 1 percent from $435.0 million in the corresponding period last year. Net income for the quarter was $23.5 million o

    8/5/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Schedules Second Quarter 2025 Earnings Release and Conference Call

    ENGLEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release second quarter 2025 earnings results on Tuesday, August 5, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 6, 2025, at 10:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal

    7/2/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Reports First Quarter 2025 Financial Results

    Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

    5/8/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Leadership Updates

    Live Leadership Updates

    View All

    Innospec Appoints Leslie J. Parrette as Non-Employee Director

    ENGLEWOOD, Colo., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it has appointed Mr. Leslie J. Parrette as a non-employee director, effective January 1, 2022. Mr. Parrette has 14 years experience in private practice as a corporate and transaction lawyer. He subsequently spent 20 years as General Counsel for public companies in domestic and international markets. Most recently, he served as Senior Vice President, General Counsel, Compliance Officer and Corporate Secretary of Novelis Inc., a leading producer of flat-rolled aluminum products and the world's largest recycler of aluminum. He is Founder and President of One Page Thinking, a data visualizatio

    12/6/21 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    SEC Filings

    View All

    SEC Form 10-Q filed by Innospec Inc.

    10-Q - INNOSPEC INC. (0001054905) (Filer)

    8/6/25 10:25:38 AM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form 8-K filed by Innospec Inc.

    8-K - INNOSPEC INC. (0001054905) (Filer)

    8/6/25 6:07:39 AM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form SD filed by Innospec Inc.

    SD - INNOSPEC INC. (0001054905) (Filer)

    5/30/25 6:04:36 AM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parrette Leslie J bought $15,135 worth of shares (143 units at $105.84), increasing direct ownership by 3% to 4,734 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    8/14/24 6:31:38 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Parrette Leslie J bought $24,867 worth of shares (189 units at $131.57), increasing direct ownership by 4% to 4,591 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    5/20/24 6:07:17 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Parrette Leslie J bought $50,824 worth of shares (410 units at $123.96), increasing direct ownership by 13% to 3,620 units (SEC Form 4)

    4 - INNOSPEC INC. (0001054905) (Issuer)

    2/23/24 6:19:14 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Innospec upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Innospec from Neutral to Buy and set a new price target of $115.00

    4/21/25 8:30:53 AM ET
    $IOSP
    Major Chemicals
    Industrials

    Seaport Research Partners initiated coverage on Innospec

    Seaport Research Partners initiated coverage of Innospec with a rating of Neutral

    3/30/22 7:37:48 AM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Financials

    Live finance-specific insights

    View All

    Innospec Reports Second Quarter 2025 Financial Results

    Strong growth in Fuel Specialties operating income offsetting lower results in our other businesses Focus on sequential gross margin and operating income improvement in the second half of the year Debt-free balance sheet with over $266 million in net cash; $8.2 million in share repurchases GAAP EPS 94 cents and adjusted non-GAAP EPS $1.26 ENGLEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the second quarter ended June 30, 2025. Total revenues for the second quarter were $439.7 million, an increase of 1 percent from $435.0 million in the corresponding period last year. Net income for the quarter was $23.5 million o

    8/5/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Schedules Second Quarter 2025 Earnings Release and Conference Call

    ENGLEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release second quarter 2025 earnings results on Tuesday, August 5, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 6, 2025, at 10:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal

    7/2/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    Innospec Reports First Quarter 2025 Financial Results

    Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

    5/8/25 4:45:00 PM ET
    $IOSP
    Major Chemicals
    Industrials

    $IOSP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

    2/13/24 5:06:27 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

    2/9/24 2:18:58 PM ET
    $IOSP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

    1/12/24 8:24:55 AM ET
    $IOSP
    Major Chemicals
    Industrials